US Stock MarketDetailed Quotes

CLPT ClearPoint Neuro

Watchlist
  • 15.750
  • -0.730-4.43%
Close Dec 27 16:00 ET
  • 15.490
  • -0.260-1.65%
Post 20:01 ET
434.46MMarket Cap-22.83P/E (TTM)

ClearPoint Neuro Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
33.24%-1.2M
47.43%-2.67M
32.39%-3.84M
15.14%-13.72M
61.86%-1.17M
53.37%-1.8M
-1.89%-5.08M
-33.05%-5.68M
-27.33%-16.17M
13.71%-3.07M
Net income from continuing operations
-3.43%-4.97M
37.49%-4.41M
26.08%-4.15M
-34.40%-22.09M
-5.34%-4.62M
-26.95%-4.81M
-63.89%-7.05M
-41.68%-5.61M
-14.05%-16.44M
-5.69%-4.39M
Depreciation and amortization
17.02%495K
36.58%463K
74.91%474K
87.52%1.46M
177.12%424K
148.82%423K
44.26%339K
23.74%271K
12.28%777K
-14.53%153K
Other non cash items
57.14%22K
132.56%14K
127.27%15K
69.87%-69K
113.51%15K
111.48%14K
-377.78%-43K
-523.08%-55K
-153.88%-229K
-265.67%-111K
Change In working capital
149.36%1.35M
30.36%-172K
12.69%-1.54M
91.70%-356K
749.62%1.11M
145.06%543K
86.54%-247K
-27.90%-1.77M
-154.69%-4.29M
121.62%131K
-Change in receivables
-441.89%-401K
-49.01%-602K
559.78%846K
-754.98%-1.8M
-248.12%-1.14M
-489.47%-74K
65.05%-404K
-218.71%-184K
67.93%-211K
305.79%771K
-Change in inventory
346.15%754K
-155.51%-373K
109.17%53K
128.18%1.25M
189.12%983K
111.03%169K
174.17%672K
34.32%-578K
-157.93%-4.42M
-6.88%-1.1M
-Change in prepaid assets
-43.74%382K
-15.91%-459K
492.86%165K
90.71%-113K
-436.36%-354K
585.00%679K
65.20%-396K
-132.81%-42K
-360.61%-1.22M
-119.70%-66K
-Change in payables and accrued expense
187.31%647K
144.76%1.66M
2.92%-931K
-140.79%-649K
11.31%374K
-228.65%-741K
-50.62%677K
-38.58%-959K
23.81%1.59M
352.63%336K
-Change in other current assets
-102.13%-1K
--0
---39K
466.67%22K
--0
4,600.00%47K
---25K
--0
90.91%-6K
2.63%-37K
-Change in other current liabilities
10.00%-234K
-56.46%-230K
-17.12%-171K
-39.56%-755K
-43.26%-202K
-87.05%-260K
-10.53%-147K
-14.06%-146K
-25.23%-541K
-17.50%-141K
-Change in other working capital
-71.37%207K
73.56%-165K
-1,116.67%-1.46M
229.51%1.7M
291.91%1.45M
7,130.00%723K
-591.34%-624K
1,957.14%144K
212.12%515K
93.23%371K
Cash from discontinued investing activities
Operating cash flow
33.24%-1.2M
47.43%-2.67M
32.39%-3.84M
15.14%-13.72M
61.86%-1.17M
53.37%-1.8M
-1.89%-5.08M
-33.05%-5.68M
-27.33%-16.17M
13.71%-3.07M
Investing cash flow
Cash flow from continuing investing activities
94.89%-12K
0
0
183.36%8.95M
-101.60%-188K
62.76%-235K
143.89%9.51M
25.41%-138K
-6,290.48%-10.74M
31,010.53%11.75M
Net PPE purchase and sale
94.89%-12K
--0
--0
-183.40%-717K
46.15%-21K
-240.58%-235K
-325.00%-323K
-100.00%-138K
-50.60%-253K
-2.63%-39K
Net intangibles purchase and sale
--0
----
----
62.60%-334K
22.33%-167K
--0
----
----
---893K
---215K
Net investment purchase and sale
--0
----
----
204.28%10M
--0
--0
----
----
---9.59M
--12M
Cash from discontinued investing activities
Investing cash flow
94.89%-12K
--0
--0
183.36%8.95M
-101.60%-188K
62.76%-235K
143.89%9.51M
25.41%-138K
-6,290.48%-10.74M
31,010.53%11.75M
Financing cash flow
Cash flow from continuing financing activities
-10,956.04%-10.06M
-32.49%160K
321,160.00%16.05M
-27.63%296K
-30.18%155K
72.34%-91K
-53.80%237K
-266.67%-5K
-99.13%409K
362.50%222K
Net common stock issuance
--0
--0
--16.18M
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
--0
-8.28%288K
--21K
-32.08%506K
-13.51%192K
--0
-38.79%314K
--0
8.13%745K
111.43%222K
Net other financing activities
32.97%-61K
-66.23%-128K
-2,920.00%-151K
37.50%-210K
---37K
---91K
---77K
---5K
43.91%-336K
--0
Cash from discontinued financing activities
Financing cash flow
-10,956.04%-10.06M
-32.49%160K
321,160.00%16.05M
-27.63%296K
-30.18%155K
72.34%-91K
-53.80%237K
-266.67%-5K
-99.13%409K
362.50%222K
Net cash flow
Beginning cash position
24.11%32.85M
62.23%35.35M
-16.20%23.14M
-48.96%27.62M
30.09%24.34M
12.50%26.46M
-56.12%21.79M
-48.96%27.62M
169.21%54.11M
-67.54%18.71M
Current changes in cash
-431.20%-11.27M
-153.68%-2.51M
309.74%12.21M
83.11%-4.48M
-113.50%-1.2M
55.90%-2.12M
117.88%4.67M
-30.82%-5.82M
-177.90%-26.49M
351.36%8.9M
End cash Position
-11.38%21.57M
24.11%32.85M
62.23%35.35M
-16.20%23.14M
-16.20%23.14M
30.09%24.34M
12.50%26.46M
-56.12%21.79M
-48.96%27.62M
-48.96%27.62M
Free cash flow
40.37%-1.21M
52.06%-2.67M
34.00%-3.84M
14.68%-14.77M
59.11%-1.36M
54.70%-2.03M
-10.05%-5.57M
-30.62%-5.82M
-34.57%-17.31M
7.55%-3.32M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 33.24%-1.2M47.43%-2.67M32.39%-3.84M15.14%-13.72M61.86%-1.17M53.37%-1.8M-1.89%-5.08M-33.05%-5.68M-27.33%-16.17M13.71%-3.07M
Net income from continuing operations -3.43%-4.97M37.49%-4.41M26.08%-4.15M-34.40%-22.09M-5.34%-4.62M-26.95%-4.81M-63.89%-7.05M-41.68%-5.61M-14.05%-16.44M-5.69%-4.39M
Depreciation and amortization 17.02%495K36.58%463K74.91%474K87.52%1.46M177.12%424K148.82%423K44.26%339K23.74%271K12.28%777K-14.53%153K
Other non cash items 57.14%22K132.56%14K127.27%15K69.87%-69K113.51%15K111.48%14K-377.78%-43K-523.08%-55K-153.88%-229K-265.67%-111K
Change In working capital 149.36%1.35M30.36%-172K12.69%-1.54M91.70%-356K749.62%1.11M145.06%543K86.54%-247K-27.90%-1.77M-154.69%-4.29M121.62%131K
-Change in receivables -441.89%-401K-49.01%-602K559.78%846K-754.98%-1.8M-248.12%-1.14M-489.47%-74K65.05%-404K-218.71%-184K67.93%-211K305.79%771K
-Change in inventory 346.15%754K-155.51%-373K109.17%53K128.18%1.25M189.12%983K111.03%169K174.17%672K34.32%-578K-157.93%-4.42M-6.88%-1.1M
-Change in prepaid assets -43.74%382K-15.91%-459K492.86%165K90.71%-113K-436.36%-354K585.00%679K65.20%-396K-132.81%-42K-360.61%-1.22M-119.70%-66K
-Change in payables and accrued expense 187.31%647K144.76%1.66M2.92%-931K-140.79%-649K11.31%374K-228.65%-741K-50.62%677K-38.58%-959K23.81%1.59M352.63%336K
-Change in other current assets -102.13%-1K--0---39K466.67%22K--04,600.00%47K---25K--090.91%-6K2.63%-37K
-Change in other current liabilities 10.00%-234K-56.46%-230K-17.12%-171K-39.56%-755K-43.26%-202K-87.05%-260K-10.53%-147K-14.06%-146K-25.23%-541K-17.50%-141K
-Change in other working capital -71.37%207K73.56%-165K-1,116.67%-1.46M229.51%1.7M291.91%1.45M7,130.00%723K-591.34%-624K1,957.14%144K212.12%515K93.23%371K
Cash from discontinued investing activities
Operating cash flow 33.24%-1.2M47.43%-2.67M32.39%-3.84M15.14%-13.72M61.86%-1.17M53.37%-1.8M-1.89%-5.08M-33.05%-5.68M-27.33%-16.17M13.71%-3.07M
Investing cash flow
Cash flow from continuing investing activities 94.89%-12K00183.36%8.95M-101.60%-188K62.76%-235K143.89%9.51M25.41%-138K-6,290.48%-10.74M31,010.53%11.75M
Net PPE purchase and sale 94.89%-12K--0--0-183.40%-717K46.15%-21K-240.58%-235K-325.00%-323K-100.00%-138K-50.60%-253K-2.63%-39K
Net intangibles purchase and sale --0--------62.60%-334K22.33%-167K--0-----------893K---215K
Net investment purchase and sale --0--------204.28%10M--0--0-----------9.59M--12M
Cash from discontinued investing activities
Investing cash flow 94.89%-12K--0--0183.36%8.95M-101.60%-188K62.76%-235K143.89%9.51M25.41%-138K-6,290.48%-10.74M31,010.53%11.75M
Financing cash flow
Cash flow from continuing financing activities -10,956.04%-10.06M-32.49%160K321,160.00%16.05M-27.63%296K-30.18%155K72.34%-91K-53.80%237K-266.67%-5K-99.13%409K362.50%222K
Net common stock issuance --0--0--16.18M----------0--0--0--------
Proceeds from stock option exercised by employees --0-8.28%288K--21K-32.08%506K-13.51%192K--0-38.79%314K--08.13%745K111.43%222K
Net other financing activities 32.97%-61K-66.23%-128K-2,920.00%-151K37.50%-210K---37K---91K---77K---5K43.91%-336K--0
Cash from discontinued financing activities
Financing cash flow -10,956.04%-10.06M-32.49%160K321,160.00%16.05M-27.63%296K-30.18%155K72.34%-91K-53.80%237K-266.67%-5K-99.13%409K362.50%222K
Net cash flow
Beginning cash position 24.11%32.85M62.23%35.35M-16.20%23.14M-48.96%27.62M30.09%24.34M12.50%26.46M-56.12%21.79M-48.96%27.62M169.21%54.11M-67.54%18.71M
Current changes in cash -431.20%-11.27M-153.68%-2.51M309.74%12.21M83.11%-4.48M-113.50%-1.2M55.90%-2.12M117.88%4.67M-30.82%-5.82M-177.90%-26.49M351.36%8.9M
End cash Position -11.38%21.57M24.11%32.85M62.23%35.35M-16.20%23.14M-16.20%23.14M30.09%24.34M12.50%26.46M-56.12%21.79M-48.96%27.62M-48.96%27.62M
Free cash flow 40.37%-1.21M52.06%-2.67M34.00%-3.84M14.68%-14.77M59.11%-1.36M54.70%-2.03M-10.05%-5.57M-30.62%-5.82M-34.57%-17.31M7.55%-3.32M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
0.00%
Petroleo Brasileiro SA Petrobras
PBR
-0.13%
Vale SA
VALE
-0.45%
Meta Platforms
META
-0.59%
Adobe
ADBE
-0.82%

Unlock the Full List

Investment Theme Brain-Computer Interface
Brain-Computer Interface
Intraday-2.29%